LAUSR

Abstract Background Whether second-generation antipsychotic long-acting injection (SGA-LAI) reduces psychotic symptoms at relapse compared with oral antipsychotics remains unclear. The present study investigated the effects of SGA-LAI on the time (in hours) of restrictive interventions in hospitalization by conducting a retrospective observational 4-year mirror-image study at a single medical center in Japan. Method We performed a retrospective observational mirror-image study conducted between November 2013 and January 2018. Data were initially retrieved from 101 patients. The 38 patients with schizophrenia who met the inclusion criteria were enrolled in the analysis. The primary outcome was the time of restrictive interventions and the secondary outcomes included the number of hospitalizations (total, voluntary, and involuntary) and bed days compared 2 years before and after initiating SGA-LAI. The restrictive interventions were defined as seclusion and physical restraints. Results The mean time of restrictive interventions significantly decreased from 43.7 to 3.03 (P = 0.021). The number of admissions and the total number of bed days in post–SGA-LAI fell from 1.03 to 0.61 (P = 0.011) and 130 to 39.3 (P = 0.003), respectively, compared with pre–SGA-LAI. In particular, the number of involuntary admissions was significantly reduced (0.50–0.26, P = 0.039). Conclusions The findings indicate that SGA-LAI reduced the time of restrictive interventions and the number of involuntary admissions. Moreover, SGA-LAI may contribute to mild psychiatric symptoms during relapse.